Munich, Germany, 21 October 2018 - Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection ...
Oncology trial RTOG 0232 comparing a combined treatment of external beam therapy and brachytherapy (EBT+B) to transperineal interstitial permanent brachytherapy ...
Data from a validation study of NRG-RTOG 0521 suggests that, while there is no association between an elevated level of ...
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but ...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - A combination of the immune checkpoint blocker, ...
New research suggests that rising childhood obesity rates are causing more adolescents to develop a debilitating hip disease requiring urgent ...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - Radiotherapy to the prostate improves overall survival ...
University of Colorado Boulder engineers have developed a 3D printing technique that allows for localized control of an object's firmness, ...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - Two-year maintenance therapy with olaparib, a PARP ...
Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (Oct. 22, 2018) - Biofeedback therapy used at home is about ...
A new study reveals that Hispanic HIV-infected adults in the United States are at a higher risk of developing cancers ...
Credit: Osaka University Osaka, Japan -- Over 1 billion years ago, a relationship began between the ancestor of all living ...
ESMO 2018 abstract LBA21 - "InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) ...
Credit: Dong-Ha Bhang, Penn Medicine: Nature Communications PHILADELPHIA - Researchers have discovered a way to grow human stem cells destined ...
Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines ...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - A high concentration of multi-strain probiotic helps ...
Munich, Germany, 20 October 2018 - Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the ...
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Epigenetic therapy with histone deacetylase (HDAC) inhibitors ...
(European Society for Medical Oncology) Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced ...
Credit: Duke-NUS Medical School Singapore, 22 October 2018 - Global efforts in immuno-oncology have received a major boost, with a ...
